Log In
BCIQ
Print this Print this
 

Typhim Vi

Also known as: Vi-rEPA vaccine

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionPurified capsular Vi polysaccharide antigen extracted from Salmonella typhi Ty2
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationTyphoid
Indication DetailsPrevent typhoid fever
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today